Explore
Upload

DocSlides is a free service to upload presentations and documents.

Upload Now

Search Results for 'Rivaroxaban Oral'

Rivaroxaban Oral published presentations and documents on DocSlides.

New Oral Anticoagulant

New Oral Anticoagulant

  • mitsue-stanley
  • 80 Slides

R2 Patcharee Seesongsom. R2 . Sirada. . Phoja...

Rivaroxaban compared with enoxaparin for the prevention of

Rivaroxaban compared with enoxaparin for the prevention of

  • luanne-stotts
  • 21 Slides

Alexander T Cohen . On behalf of the MAGELLAN Ste...

Rivaroxaban or Aspirin for Extended Treatment of Venous Thr

Rivaroxaban or Aspirin for Extended Treatment of Venous Thr

  • yoshiko-marsland
  • 25 Slides

(EINSTEIN CHOICE). Ryan Sparks, . PharmD. , BCPS....

A Multicenter Randomized Trial Evaluating Clinically Significant Bleeding with Low-Dose Rivaroxaban

A Multicenter Randomized Trial Evaluating Clinically Significant Bleeding with Low-Dose Rivaroxaban

  • celsa-spraggs
  • 0 Slides

Magnus Ohman MB, on behalf of the GEMINI-ACS-1 In...

Rivaroxaban Plus Aspirin in Patients With and Without Heart Failure and Chronic Coronary or Peripheral Artery Disease:

Rivaroxaban Plus Aspirin in Patients With and Without Heart Failure and Chronic Coronary or Peripheral Artery Disease:

  • giovanna-bartolotta
  • 15 Slides

Rivaroxaban Plus Aspirin in Patients With and Wit...

Novel Oral Anticoagulants

Novel Oral Anticoagulants

  • natalia-silvester
  • 88 Slides

(. N. OAC). Dan . Moellentin. , . PharmD. , BCPS,...

Ima A. Kusuma , MD, FIHA

Ima A. Kusuma , MD, FIHA

  • hirook
  • 33 Slides

“JIH. ” Hospital, Yogyakarta, Indonesia. The U...

Thromboembolic protocols

Thromboembolic protocols

  • cecilia
  • 27 Slides

& safe anticoagulant prescribing. July 2020. D...

MAGELLAN Primary efficacy endpoint at 10 days (DVT, symptomatic PE,

MAGELLAN Primary efficacy endpoint at 10 days (DVT, symptomatic PE,

  • HoneyBun
  • 1 Slides

VTE death. ) for . rivaroxaban. vs. . enoxaparin....

Recent ACS: STEMI, NSTEMI, UA

Recent ACS: STEMI, NSTEMI, UA

  • danika-pritchard
  • 20 Slides

Stabilized 1-7 Days Post-Index Event. Exclusions:...

A New Era in Anticoagulation Management

A New Era in Anticoagulation Management

  • debby-jeon
  • 46 Slides

Allyson Sarigianis, Pharm.D.. October 19, 2013. O...

A Multicenter Randomized Trial Evaluating Clinically Signif

A Multicenter Randomized Trial Evaluating Clinically Signif

  • ellena-manuel
  • 20 Slides

Magnus Ohman MB, on behalf of the GEMINI-ACS-1 In...

R eal-world

R eal-world

  • liane-varnes
  • 20 Slides

EVI. dence. on . S. troke prevention . I. n pati...

A Multicenter Randomized Trial Evaluating Clinically Signif

A Multicenter Randomized Trial Evaluating Clinically Signif

  • giovanna-bartolotta
  • 20 Slides

Magnus Ohman MB, on behalf of the GEMINI-ACS-1 In...

Stroke, Bleeding, and

Stroke, Bleeding, and

  • lois-ondreau
  • 7 Slides

Mortality Risks . in . Elderly Medicare Beneficia...

A New Era in Anticoagulation Management

A New Era in Anticoagulation Management

  • alexa-scheidler
  • 0 Slides

Allyson Sarigianis, Pharm.D.. October 19, 2013. O...

CAD/PAD in Primary Care CV Risk in Stable Outpatients

CAD/PAD in Primary Care CV Risk in Stable Outpatients

  • stefany-barnette
  • 0 Slides

Stratified by Baseline CV Risk Category. Aspirin ...

Dr. Phil Wells on behalf of the EINSTEIN CHOICE Steering Committee and Investigators

Dr. Phil Wells on behalf of the EINSTEIN CHOICE Steering Committee and Investigators

  • yoshiko-marsland
  • 18 Slides

Dr. Phil Wells on behalf of the EINSTEIN CHOICE ...

A ssessment of D ual antiplatelet therapy versus

A ssessment of D ual antiplatelet therapy versus

  • stefany-barnette
  • 22 Slides

A ssessment of D ual antiplatelet therapy versus...

A ssessment of D ual antiplatelet therapy versus

A ssessment of D ual antiplatelet therapy versus

  • coursion
  • 22 Slides

R. ivaroxaban . I. n atrial . F. ibrillation patie...

Rivaroxaban in stable peripheral or carotid artery disease

Rivaroxaban in stable peripheral or carotid artery disease

  • basidell
  • 17 Slides

Sonia Anand, on . behalf of the COMPASS Steering C...

X- VeRT CV death, stroke/TIA, non-CNS systemic embolism, or MI: 0.51% of the

X- VeRT CV death, stroke/TIA, non-CNS systemic embolism, or MI: 0.51% of the

  • LittleMissPerfect
  • 1 Slides

rivaroxaban. group vs. 1.02% of the vitamin K ant...

Review on NOACs Studies Dr.

Review on NOACs Studies Dr.

  • BlessedBeyondMeasure
  • 37 Slides

Kourosh. . Sadeghi. Tehran University of medical ...

Reversing Course: Managing Anticoagulation and Antiplatelet Bleeding

Reversing Course: Managing Anticoagulation and Antiplatelet Bleeding

  • kyle585
  • 20 Slides

Paul P. . Dobesh. , . Pharm.D. , FCCP, BCPS, BCCP....

Update on the New Oral Anticoagulants

Update on the New Oral Anticoagulants

  • sherrill-nordquist
  • 39 Slides

Eliot Williams, MD PhD. Division of Hematology &a...

Safe and Effective Use of Novel Oral Anticoagulants for Atrial Fibrillation: What You Need to Know

Safe and Effective Use of Novel Oral Anticoagulants for Atrial Fibrillation: What You Need to Know

  • dsuser1
  • 64 Slides

Christopher Granger, . MD. Sean Pokorney, MD. . D...

The thick and thin of it: Reviewing Anticoagulant Options

The thick and thin of it: Reviewing Anticoagulant Options

  • oneill
  • 26 Slides

Lanae Fox, . PharmD. , BCPS. I have no financial d...

Spotlight Case New Oral Anticoagulants

Spotlight Case New Oral Anticoagulants

  • skylar
  • 24 Slides

This presentation is based on the . December 2013....

DentalUpdateNovember 2015A New Generation of Antiplatelet and Anticoag

DentalUpdateNovember 2015A New Generation of Antiplatelet and Anticoag

  • cecilia
  • 9 Slides

Steven Johnston, BDS, MSc, MFDS RCS(Ed), Dental Of...

Oral Tradition, Oral History, & the

Oral Tradition, Oral History, & the

  • pasty-toler
  • 0 Slides

UW-Madison Oral History Project. IWU Research . S...

Oral Cancer Screening People’s lives can be saved through early detection of oral, head and neck

Oral Cancer Screening People’s lives can be saved through early detection of oral, head and neck

  • phoebe-click
  • 37 Slides

Adriana Clark, DDS. 1. Agenda. Introduction. Ora...

ORAL CANCER Journal of Oral Health and Dental Management

ORAL CANCER Journal of Oral Health and Dental Management

  • freya
  • 7 Slides

INTRODUCTION. Cancer is defined as the uncontrolla...

ORAL CAVITY The oral cavity is formed by a bewildering array of tissues which function in or are as

ORAL CAVITY The oral cavity is formed by a bewildering array of tissues which function in or are as

  • ash
  • 20 Slides

secretory. products into the oral cavity, the sal...

Oral candidiasis Oral Thrush

Oral candidiasis Oral Thrush

  • trinity
  • 1 Slides

Single Point Lesson Oral candidiasis, also known ...

Med Oral Patol Oral Cir Bucal 2007

Med Oral Patol Oral Cir Bucal 2007

  • caitlin
  • 3 Slides

E388 12:E388-90. Dentigerous cyst associated with ...

Med Oral Patol Oral Cir Bucal 2x0011x0011x0018x001C

Med Oral Patol Oral Cir Bucal 2x0011x0011x0018x001C

  • iris
  • 4 Slides

Oral osarcoma Med Oral Patol Oral Cir Bucal 2�...

Med Oral Patol Oral Cir Bucal 200x0018x001C

Med Oral Patol Oral Cir Bucal 200x0018x001C

  • iris
  • 7 Slides

Antibiotic use in dental practice Oral Patol Oral...

Med Oral Patol Oral Cir Bucal Sep 114 9e41620 Reappearance of

Med Oral Patol Oral Cir Bucal Sep 114 9e41620 Reappearance of

  • hailey
  • 5 Slides

Journal section: Oral Medicine and PathologyPublic...

Differential diagnosis and management of oral ulcershile many oral ulc

Differential diagnosis and management of oral ulcershile many oral ulc

  • dandy
  • 7 Slides

Department of Pediatric Dentistry, University of T...

Riverside Oral Surgery

Riverside Oral Surgery

  • riversidenjoralsurgery
  • 100 Slides

Oral and maxillofacial surgery requires additional...

Copyright © 2024 DocSlides. All Rights Reserved